Roivant Sciences Ltd. (ROIV)
USD 11.48
(-0.86%)
USD 11.48
(-0.86%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 773.95 Million USD | -1.03% |
| 2023 | 782.01 Million USD | 43.18% |
| 2022 | 546.18 Million USD | 3.51% |
| 2021 | 527.68 Million USD | 43.25% |
| 2020 | 368.35 Million USD | -18.24% |
| 2019 | 450.51 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 802.5 Million USD | -22.33% |
| 2024 Q2 | 739.91 Million USD | 4.13% |
| 2024 FY | 773.95 Million USD | -1.03% |
| 2024 Q3 | 728.09 Million USD | -1.6% |
| 2024 Q4 | 773.95 Million USD | 6.3% |
| 2023 Q1 | 822.51 Million USD | 50.59% |
| 2023 Q2 | 701.38 Million USD | -14.73% |
| 2023 Q4 | 782.01 Million USD | 0.8% |
| 2023 Q3 | 775.82 Million USD | 10.61% |
| 2023 FY | 782.01 Million USD | 43.18% |
| 2022 Q2 | 652 Million USD | 37.3% |
| 2022 FY | 546.18 Million USD | 3.51% |
| 2022 Q4 | 546.18 Million USD | -1.07% |
| 2022 Q1 | 474.86 Million USD | -10.01% |
| 2022 Q3 | 552.11 Million USD | -15.32% |
| 2021 Q3 | 400 Million USD | 0.0% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q4 | 527.68 Million USD | 31.92% |
| 2021 FY | 527.68 Million USD | 43.25% |
| 2020 Q4 | 368.35 Million USD | 0.0% |
| 2020 FY | 368.35 Million USD | -18.24% |
| 2019 FY | 450.51 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Absci Corporation | 58.3 Million USD | -1227.444% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -119.34% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 80.893% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -23892.792% |
| Apollomics, Inc. | 14.15 Million USD | -5368.473% |
| 180 Life Sciences Corp. | 5.38 Million USD | -14266.493% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -14681.379% |
| Bicycle Therapeutics plc | 224.41 Million USD | -244.88% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -2713.249% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -494.388% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -1414.496% |
| Chimerix, Inc. | 19.74 Million USD | -3819.742% |
| CRISPR Therapeutics AG | 346.76 Million USD | -123.19% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -290.251% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -770.97% |
| Fortress Biotech, Inc. | 165.93 Million USD | -366.408% |
| Fortress Biotech, Inc. | 165.93 Million USD | -366.408% |
| Gritstone bio, Inc. | 125.91 Million USD | -514.644% |
| Allakos Inc. | 74.79 Million USD | -934.793% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -201.177% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -1025.602% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 36.071% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -5247.564% |
| Innoviva, Inc. | 568.55 Million USD | -36.127% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -109683.215% |
| NLS Pharmaceutics AG | 10.68 Million USD | -7146.613% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -2843.459% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -59469.626% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -5785.574% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -3045.383% |
| ImmuCell Corporation | 18.81 Million USD | -4013.484% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -2641.986% |
| Incyte Corporation | 1.59 Billion USD | 51.393% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -1292.12% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -191516.16% |
| Mustang Bio, Inc. | 17.61 Million USD | -4292.718% |
| MiMedx Group, Inc. | 96.33 Million USD | -703.439% |
| MEI Pharma, Inc. | 8.35 Million USD | -9163.351% |
| MacroGenics, Inc. | 154.2 Million USD | -401.892% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -43939.836% |
| Mereo BioPharma Group plc | 15.96 Million USD | -4748.722% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -25070.447% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -402.101% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | -10.951% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -806.713% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -12596.079% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -15225.802% |
| NextCure, Inc. | 14.99 Million USD | -5060.719% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -2748.662% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -19047.773% |
| Onconetix, Inc. | 23.18 Million USD | -3238.755% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -11491.328% |
| Opthea Limited | 264.6 Million USD | -192.498% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -1276.408% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -6293.823% |
| PDS Biotechnology Corporation | 33.25 Million USD | -2227.039% |
| Precigen, Inc. | 41.64 Million USD | -1758.498% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -6391.805% |
| Prime Medicine, Inc. | 60.78 Million USD | -1173.368% |
| PureTech Health plc | 125.58 Million USD | -516.288% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -949.186% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 89.11% |
| Replimune Group, Inc. | 113.21 Million USD | -583.62% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -13807.776% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -430.581% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -21831.929% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -194.955% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -11613.642% |
| Sesen Bio, Inc. | 30.98 Million USD | -2397.912% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -838.887% |
| Solid Biosciences Inc. | 38.45 Million USD | -1912.463% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -1218.848% |
| SciSparc Ltd. | 1.59 Million USD | -48423.699% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -141.042% |
| TG Therapeutics, Inc. | 169.08 Million USD | -357.73% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -1481.691% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -53497.853% |
| Travere Therapeutics, Inc. | 588.1 Million USD | -31.602% |
| UroGen Pharma Ltd. | 243.52 Million USD | -217.815% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -1151.663% |
| XOMA Corporation | 145.58 Million USD | -431.634% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -520.971% |
| AbCellera Biologics Inc. | 335.77 Million USD | -130.497% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -7818.488% |
| Cassava Sciences, Inc. | 14.19 Million USD | -5352.293% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -2100.161% |
| Precision BioSciences, Inc. | 140.92 Million USD | -449.214% |
| Dyadic International, Inc. | 2.34 Million USD | -32965.715% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -18626.18% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -4658.981% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -8547.52% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -2389.315% |
| IGM Biosciences, Inc. | 220.17 Million USD | -251.514% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -704.868% |
| Acelyrin, Inc. | 86.35 Million USD | -796.266% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -1473.843% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -492.128% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -21832.936% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -412.929% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -410.82% |
| Senti Biosciences, Inc. | 52.57 Million USD | -1372.205% |
| Mesoblast Limited | 188.79 Million USD | -309.937% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -328.1% |
| ChromaDex Corporation | 26.5 Million USD | -2819.696% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -8944.473% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -184.242% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -47568.476% |
| Seer, Inc. | 39.36 Million USD | -1866.094% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -122.669% |
| Novavax, Inc. | 2.57 Billion USD | 69.912% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -9959.145% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -461.649% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -4100.559% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -714.028% |
| Celcuity Inc. | 51.45 Million USD | -1404.28% |
| ContextLogic Inc. | 206 Million USD | -275.705% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | -59.053% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -982.755% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 89.891% |
| Amarin Corporation plc | 279.58 Million USD | -176.82% |
| AnaptysBio, Inc. | 364.28 Million USD | -112.458% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -6032.264% |
| Aptorum Group Limited | 5.25 Million USD | -14623.066% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | -3.854% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | -61.783% |
| Ardelyx, Inc. | 130.76 Million USD | -491.875% |
| Celularity Inc. | 102.92 Million USD | -651.929% |
| Omeros Corporation | 403.25 Million USD | -91.928% |
| Humacyte, Inc. | 114.67 Million USD | -574.898% |
| Immunocore Holdings plc | 228.15 Million USD | -239.218% |
| IO Biotech, Inc. | 17.55 Million USD | -4308.481% |
| GT Biopharma, Inc. | 6.63 Million USD | -11568.22% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -4334.752% |
| Summit Therapeutics Inc. | 125.25 Million USD | -517.892% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -39468.149% |
| Pulmatrix, Inc. | 15.96 Million USD | -4748.418% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -208.584% |
| Evogene Ltd. | 17.99 Million USD | -4202.129% |
| CorMedix Inc. | 11.91 Million USD | -6394.241% |
| BioLineRx Ltd. | 50.7 Million USD | -1426.474% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -8162.549% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -13588.592% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 71.564% |
| scPharmaceuticals Inc. | 57.26 Million USD | -1251.623% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -3339.638% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -574.105% |
| NLS Pharmaceutics AG | 10.68 Million USD | -7146.613% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -11613.642% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -1621.234% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -26867.003% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -11281.662% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -1025.308% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -4011.086% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -1555.904% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -6147.592% |
| Daré Bioscience, Inc. | 26.32 Million USD | -2839.45% |
| bluebird bio, Inc. | 424.62 Million USD | -82.268% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 59.051% |
| DBV Technologies S.A. | 42.8 Million USD | -1708.301% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -505.64% |
| Galecto, Inc. | 5.89 Million USD | -13026.747% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -8064.922% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -2720.837% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -192.732% |
| GlycoMimetics, Inc. | 6.9 Million USD | -11113.34% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -206.276% |
| ADMA Biologics, Inc. | 193.97 Million USD | -298.994% |
| Clene Inc. | 38.95 Million USD | -1886.991% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -306.781% |
| Aptose Biosciences Inc. | 15.8 Million USD | -4795.741% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -6910.643% |
| Soligenix, Inc. | 7.27 Million USD | -10538.67% |
| Century Therapeutics, Inc. | 175.94 Million USD | -339.893% |
| Kura Oncology, Inc. | 51.66 Million USD | -1398.109% |
| Surrozen, Inc. | 8.14 Million USD | -9402.185% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -538.143% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -11601.995% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -206.397% |
| Autolus Therapeutics plc | 263.9 Million USD | -193.267% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -7283.639% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -1550.255% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -966.536% |
| GRI Bio, Inc. | 2.69 Million USD | -28596.811% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -95498.733% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -2046.411% |
| INmune Bio, Inc. | 18.86 Million USD | -4003.239% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -201.761% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2805.031% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -28370.839% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -21479.498% |
| Jaguar Health, Inc. | 45.86 Million USD | -1587.422% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -23494.215% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -1224.015% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -1450.076% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -192.35% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 5.963% |
| Verastem, Inc. | 71.18 Million USD | -987.242% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1906.203% |
| Histogen Inc. | 5.69 Million USD | -13485.273% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -17547.577% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -143.995% |
| Surrozen, Inc. | 8.14 Million USD | -9402.185% |
| Organovo Holdings, Inc. | 2.74 Million USD | -28064.229% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -246493.364% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -93499.758% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -510.734% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -7057.225% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -29583.567% |
| Kronos Bio, Inc. | 54.2 Million USD | -1327.931% |
| Turnstone Biologics Corp. | 14.14 Million USD | -5370.406% |
| Synaptogenix, Inc. | 5.52 Million USD | -13896.877% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -11541.892% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -241.201% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -354.977% |
| Exelixis, Inc. | 678.44 Million USD | -14.077% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -371.79% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | -30.249% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -5173.596% |
| ESSA Pharma Inc. | 3.49 Million USD | -22044.128% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -15109.466% |
| Avid Bioservices, Inc. | 275.66 Million USD | -180.755% |
| Insmed Incorporated | 1.66 Billion USD | 53.426% |
| MediWound Ltd. | 27.18 Million USD | -2746.776% |
| OmniAb, Inc. | 87.4 Million USD | -785.53% |
| Alector, Inc. | 487.66 Million USD | -58.705% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -91.831% |
| Zai Lab Limited | 240.17 Million USD | -222.243% |
| AlloVir, Inc. | 45.01 Million USD | -1619.322% |
| Revance Therapeutics, Inc. | 630.05 Million USD | -22.838% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -2429.423% |
| Aura Biosciences, Inc. | 29.22 Million USD | -2548.075% |
| Immunic, Inc. | 25.36 Million USD | -2950.903% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -1017.848% |
| Veracyte, Inc. | 93.71 Million USD | -725.823% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -29477.75% |
| FibroGen, Inc. | 585.72 Million USD | -32.135% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -4352.356% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -821.088% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -118408.872% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -13585.063% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -9340.754% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -821.131% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 70.442% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -2585.286% |
| XBiotech Inc. | 8.39 Million USD | -9117.018% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -5173.596% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1946.845% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -5282.523% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -1355.346% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -113.148% |
| Agenus Inc. | 462.29 Million USD | -67.415% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -2778.861% |
| Theravance Biopharma, Inc. | 169 Million USD | -357.95% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 36.332% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | -54.659% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 20.415% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -12732.686% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -493.809% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -208291.358% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -14916.463% |
| Lantern Pharma Inc. | 2.73 Million USD | -28149.738% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -1722.138% |
| Ainos, Inc. | 7.39 Million USD | -10366.996% |
| Pluri Inc. | 34.11 Million USD | -2168.858% |
| Prothena Corporation plc | 135.01 Million USD | -473.226% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -218.364% |
| Rallybio Corporation | 9.43 Million USD | -8102.13% |
| Kodiak Sciences Inc. | 213.59 Million USD | -262.353% |
| Cue Biopharma, Inc. | 24.44 Million USD | -3066.099% |
| MeiraGTx Holdings plc | 319.99 Million USD | -141.867% |
| Annexon, Inc. | 47.11 Million USD | -1542.585% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -703.089% |
| Moderna, Inc. | 4.57 Billion USD | 83.072% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -15775.959% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -908.539% |
| Blueprint Medicines Corporation | 918.64 Million USD | 15.75% |
| Immix Biopharma, Inc. | 3.72 Million USD | -20695.221% |
| CalciMedica, Inc. | 4.02 Million USD | -19114.325% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -521.624% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -801.864% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -240.281% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -178.608% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -4806.822% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -1423.949% |
| Nutriband Inc. | 1.07 Million USD | -71634.115% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -7178.783% |
| Vor Biopharma Inc. | 59.1 Million USD | -1209.477% |
| Alkermes plc | 933.53 Million USD | 17.095% |
| ProKidney Corp. | 29.21 Million USD | -2549.072% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -975.248% |
| Arcellx, Inc. | 339.75 Million USD | -127.799% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 59.027% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -417.836% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -775.107% |
| Atai Life Sciences N.V. | 49.16 Million USD | -1474.291% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -2384.416% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -4208.835% |
| MediciNova, Inc. | 3.89 Million USD | -19788.024% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -4134.11% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -51351.396% |
| GeoVax Labs, Inc. | 3.51 Million USD | -21888.044% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -94.823% |
| Biomea Fusion, Inc. | 30.69 Million USD | -2421.841% |
| RenovoRx, Inc. | 4.46 Million USD | -17229.893% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -2380.539% |
| Geron Corporation | 146.12 Million USD | -429.644% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3963.172% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -2313.926% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -948.859% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -784.69% |
| Royalty Pharma plc | 6.29 Billion USD | 87.71% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -2191.836% |
| Imunon, Inc. | 8.53 Million USD | -8972.852% |
| BioAtla, Inc. | 48.98 Million USD | -1479.947% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -492.595% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -5344.622% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -309.161% |
| Structure Therapeutics Inc. | 29.05 Million USD | -2564.118% |
| 89bio, Inc. | 59.96 Million USD | -1190.718% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -2198.984% |
| aTyr Pharma, Inc. | 31.59 Million USD | -2349.451% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -1151.885% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -1499.01% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -9387.022% |
| Akari Therapeutics, Plc | 4.58 Million USD | -16783.791% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -4264.447% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 53.078% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -467.751% |
| Liquidia Corporation | 73.13 Million USD | -958.209% |
| Entera Bio Ltd. | 1.37 Million USD | -56024.22% |
| GH Research PLC | 6.7 Million USD | -11449.813% |
| Vericel Corporation | 127.7 Million USD | -506.048% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1916.395% |
| Xencor, Inc. | 283.55 Million USD | -172.942% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -25822.212% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -28370.839% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -20499.607% |
| Vaxcyte, Inc. | 167.44 Million USD | -362.202% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1998.742% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -647.564% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -191516.16% |
| Portage Biotech Inc. | 4.45 Million USD | -17292.202% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -51351.396% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -3257.714% |
| OncoCyte Corporation | 49.29 Million USD | -1469.948% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -18608.955% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -96949.345% |
| Purple Biotech Ltd. | 10 Million USD | -7635.662% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -3016.38% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -11550.655% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -374.859% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -13276.305% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -6273.131% |
| United Therapeutics Corporation | 1.18 Billion USD | 34.533% |
| HilleVax, Inc. | 78.9 Million USD | -880.817% |
| Silo Pharma, Inc. | 1.56 Million USD | -49219.301% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -57849.525% |
| Pharming Group N.V. | 244.07 Million USD | -217.099% |
| Tharimmune, Inc. | 1.81 Million USD | -42540.958% |
| Genprex, Inc. | 3.25 Million USD | -23683.145% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -3501.289% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -2753.914% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -1511.663% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -375605.34% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -215757.57% |
| OKYO Pharma Limited | 7.42 Million USD | -10329.444% |
| Savara Inc. | 37.19 Million USD | -1980.966% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -2567.424% |
| Curis, Inc. | 57.61 Million USD | -1243.389% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1874.38% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -3617.532% |
| BeiGene, Ltd. | 2.23 Billion USD | 65.352% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -3538.023% |
| Erasca, Inc. | 78.61 Million USD | -884.535% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -118015.321% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -118015.321% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -10964.375% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -46636.292% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -4433.995% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -2022.978% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -1291.126% |
| Adicet Bio, Inc. | 37.12 Million USD | -1985.003% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | -25.295% |
| Aditxt, Inc. | 28.53 Million USD | -2612.621% |
| Adagene Inc. | 45.16 Million USD | -1613.448% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -428205.875% |
| Quantum-Si incorporated | 26.63 Million USD | -2806.211% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -25338.579% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -573.231% |
| Compugen Ltd. | 55.77 Million USD | -1287.634% |
| Generation Bio Co. | 171.63 Million USD | -350.943% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -6600.892% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1750.19% |
| Invivyd, Inc. | 51.71 Million USD | -1396.631% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -741.464% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -11797.358% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -925.158% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -75703.428% |
| 2seventy bio, Inc. | 310.12 Million USD | -149.561% |
| Instil Bio, Inc. | 99.8 Million USD | -675.496% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -2041.964% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -56689.635% |
| GeoVax Labs, Inc. | 3.51 Million USD | -21888.044% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -6254.47% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -6246.582% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -1364.683% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -109.259% |
| Evaxion Biotech A/S | 17.61 Million USD | -4293.097% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -380.928% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -405.237% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -3483.945% |
| Cingulate Inc. | 10.36 Million USD | -7369.965% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -28043.745% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1975.386% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -3014.624% |
| Clearmind Medicine Inc. | 3.61 Million USD | -21339.094% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -1545.203% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3300.537% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -3756.076% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -229.042% |
| ImmunityBio, Inc. | 1.09 Billion USD | 29.02% |
| Korro Bio, Inc. | 51.75 Million USD | -1395.504% |
| Kineta, Inc. | 7.22 Million USD | -10616.602% |
| BioVie Inc. | 9.7 Million USD | -7877.145% |
| Codexis, Inc. | 49.94 Million USD | -1449.58% |
| Celularity Inc. | 102.92 Million USD | -651.929% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -588.576% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -704.132% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -224108.126% |
| Cibus, Inc. | 206.11 Million USD | -275.492% |
| IN8bio, Inc. | 8.77 Million USD | -8722.994% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -764.356% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -5553.832% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 70.271% |
| Eyenovia, Inc. | 19.78 Million USD | -3812.75% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -337.049% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -9976.201% |
| Elevation Oncology, Inc. | 34.28 Million USD | -2157.607% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -3111.556% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -6404.9% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -215.204% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -7993.203% |
| Moolec Science SA | 13.94 Million USD | -5449.898% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -1693.551% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -1431.61% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1845.779% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -9183.351% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -262786.286% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -31357.898% |
| Humacyte, Inc. | 114.67 Million USD | -574.898% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -2824.661% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -64611.789% |
| Genelux Corporation | 8.42 Million USD | -9091.841% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -11188.696% |
| Notable Labs, Ltd. | 4.42 Million USD | -17382.562% |
| Immunovant, Inc. | 48.95 Million USD | -1480.948% |
| Quantum-Si incorporated | 26.63 Million USD | -2806.211% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -24842.088% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -947.851% |
| Acasti Pharma Inc. | 11.55 Million USD | -6596.833% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -3323.4% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -3238.307% |
| PepGen Inc. | 34.63 Million USD | -2134.856% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -10981.801% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -8944.473% |
| Immuneering Corporation | 12 Million USD | -6345.121% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -246493.364% |
| Belite Bio, Inc | 4.21 Million USD | -18279.316% |
| XOMA Corporation | 145.58 Million USD | -431.634% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -31776.153% |
| Bionomics Limited | 10.15 Million USD | -7518.607% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3277.79% |
| uniQure N.V. | 624.01 Million USD | -24.027% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -428205.875% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -354.774% |
| Forte Biosciences, Inc. | 3.66 Million USD | -21011.648% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -296908.247% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -11371.069% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -9976.201% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -4352.356% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -7223.552% |
| Altimmune, Inc. | 16.54 Million USD | -4578.998% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -15779.216% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -3277.79% |
| Peak Bio, Inc. | 20.75 Million USD | -3629.289% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -600.645% |
| Benitec Biopharma Inc. | 4.96 Million USD | -15497.602% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -390.331% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -929.549% |
| Zura Bio Limited | 21.29 Million USD | -3534.947% |
| PolyPid Ltd. | 17.46 Million USD | -4330.69% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -929.549% |
| argenx SE | 444.95 Million USD | -73.941% |
| Immunome, Inc. | 28.65 Million USD | -2600.653% |
| Verona Pharma plc | 58.84 Million USD | -1215.329% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -5247.564% |
| Shattuck Labs, Inc. | 14.85 Million USD | -5108.648% |
| CervoMed Inc. | 2.59 Million USD | -29716.195% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -5976.892% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -7246.493% |
| Moolec Science SA | 13.94 Million USD | -5449.898% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -32925.461% |
| Design Therapeutics, Inc. | 11.95 Million USD | -6373.344% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -6001.805% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1888.165% |
| Achilles Therapeutics plc | 19.08 Million USD | -3954.87% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -3300.537% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -5233.561% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -92.874% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -2283.374% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -5831.085% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -14633.543% |
| Beam Therapeutics Inc. | 478.38 Million USD | -61.785% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -94.484% |
| AEON Biopharma, Inc. | 159.88 Million USD | -384.056% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -2742.489% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -2881.214% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -10080.624% |
| NeurAxis, Inc. | 1.91 Million USD | -40363.074% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -295.403% |
| Lumos Pharma, Inc. | 13.33 Million USD | -5704.793% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -3181.132% |
| Palisade Bio, Inc. | 2.73 Million USD | -28156.773% |
| Nutriband Inc. | 1.07 Million USD | -71634.115% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -302.981% |
| Neurogene Inc. | 36.54 Million USD | -2017.576% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -31554.519% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -1524.246% |
| Athira Pharma, Inc. | 30.05 Million USD | -2474.951% |
| HCW Biologics Inc. | 15.05 Million USD | -5041.881% |
| XOMA Corporation | 145.58 Million USD | -431.634% |
| Nektar Therapeutics | 267.04 Million USD | -189.82% |
| Arvinas, Inc. | 644.6 Million USD | -20.067% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -4264.447% |
| Merus N.V. | 102.15 Million USD | -657.656% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -428.837% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -713.66% |
| Rezolute, Inc. | 11.73 Million USD | -6495.816% |
| Clene Inc. | 38.95 Million USD | -1886.991% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -27081.233% |
| BeyondSpring Inc. | 48.26 Million USD | -1503.416% |
| Synlogic, Inc. | 32.89 Million USD | -2252.798% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -5196.332% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -47265.545% |
| Peak Bio, Inc. | 20.75 Million USD | -3629.289% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -1119.611% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1848.817% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -105.487% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -677.303% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -178755.211% |
| MannKind Corporation | 721.36 Million USD | -7.29% |
| Ikena Oncology, Inc. | 22.33 Million USD | -3365.203% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -37002.253% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -654.414% |
| Gossamer Bio, Inc. | 249.14 Million USD | -210.641% |
| CohBar, Inc. | 1.03 Million USD | -74776.601% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -7140.649% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -3963.172% |
| Legend Biotech Corporation | 589.93 Million USD | -31.193% |
| Mural Oncology plc | 37.92 Million USD | -1940.585% |
| Disc Medicine, Inc. | 22.87 Million USD | -3283.401% |
| Champions Oncology, Inc. | 28.03 Million USD | -2660.667% |
| REGENXBIO Inc. | 262.22 Million USD | -195.145% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -22938.759% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -6074.828% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -5662.169% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -3549.861% |
| Vaxart, Inc. | 34.02 Million USD | -2174.66% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -3695.885% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -2612.59% |
| Cellectis S.A. | 249.57 Million USD | -210.108% |
| Longeveron Inc. | 5.33 Million USD | -14401.649% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1750.721% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 67.822% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -1182.058% |
| Revolution Medicines, Inc. | 262.39 Million USD | -194.955% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -36632.463% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -8872.328% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -6458.368% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -5411.308% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -35881.079% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 84.971% |
| Denali Therapeutics Inc. | 122.96 Million USD | -529.419% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -13807.776% |
| Veru Inc. | 32.81 Million USD | -2258.699% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -11167.331% |
| Cingulate Inc. | 10.36 Million USD | -7369.965% |
| Passage Bio, Inc. | 39.26 Million USD | -1871.252% |
| Context Therapeutics Inc. | 4.19 Million USD | -18363.875% |
| Exicure, Inc. | 8.54 Million USD | -8953.141% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -2522.858% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -7280.822% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -3411.424% |
| Nuvalent, Inc. | 31.82 Million USD | -2332.055% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -12065.96% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -1128.068% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -4199.739% |
| OmniAb, Inc. | 87.4 Million USD | -785.53% |
| Anew Medical, Inc. | 8.24 Million USD | -9290.583% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1921.341% |
| Lipocine Inc. | 2.63 Million USD | -29309.655% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -2845.923% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1824.682% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -2805.031% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -798.337% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -14229.809% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -835.325% |
| Ocugen, Inc. | 23.98 Million USD | -3127.09% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -1567.751% |
| Q32 Bio Inc. | 233.12 Million USD | -231.986% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -8436.874% |
| Alumis Inc. Common Stock | 53.5 Million USD | -1346.587% |
| Equillium, Inc. | 27.95 Million USD | -2668.369% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -274.629% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -13655.093% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -12519.551% |
| Dominari Holdings Inc. | 4.63 Million USD | -16598.015% |
| Edesa Biotech, Inc. | 1.84 Million USD | -41925.274% |
| vTv Therapeutics Inc. | 29.56 Million USD | -2517.624% |
| Bio-Techne Corporation | 744.34 Million USD | -3.978% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -513.766% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -124.688% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1807.463% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -2572.767% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -737.974% |
| Nkarta, Inc. | 105.6 Million USD | -632.91% |
| BioCardia, Inc. | 4.59 Million USD | -16761.721% |
| Iterum Therapeutics plc | 32.66 Million USD | -2269.582% |